Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-330
Closed -$12K – 6661
2019
Q2
$12K Sell
330
-132
-29% -$4.52K ﹤0.01% 6512
2019
Q1
$14K Sell
462
-11,550
-96% -$353K ﹤0.01% 6460
2018
Q4
$333K Buy
+12,012
New +$330K ﹤0.01% 4186

Other funds holding ACA

Barclays's ACA Position: Q3 2026 in Review

Barclays increased its Arcosa (ACA) stake by 62% in Q3 2026, buying an estimated $1.1M and bringing the position to 19,925 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

Barclays first reported a position in ACA in Q4 2018 and has held it in 32 quarters since. The position peaked at $11.4M in Q4 2025. 368 funds tracked by Wall St. Rank hold ACA as of Q3 2026.

  • Barclays held 19,925 shares of Arcosa worth $2.91M as of Q3 2026.
  • Barclays bought 7,589 Arcosa shares in Q3 2026, an estimated $1.1M.
  • Arcosa made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2364 holding.
  • Barclays first reported a position in Arcosa in Q4 2018 and has held it in 32 quarters since.
  • Barclays's Arcosa position peaked at $11.4M in Q4 2025.
  • 368 funds tracked by Wall St. Rank held Arcosa as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.